design: Genomic DNA was isolated from 2 to 5ml of subjects' peripheral blood sample using a commercial kit (TIANGEN, China). The targeted gene capture process was completed in MyGenostics, Beijing, China. Targeted next-generation sequencing with a panel of 208 genes related to blood system diseases was adopted to detect the variants. The library was sequenced using a NextSeq500 instrument.